Welcome to LookChem.com Sign In|Join Free
  • or
(Z)-5-Fluoro-2-Methyl-(4-Pyridinylidene)-3-(N-(S-α-Hydroxymethyl)Benzyl)-Indenylacetamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1055073-24-9

Post Buying Request

1055073-24-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1055073-24-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1055073-24-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,5,5,0,7 and 3 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1055073-24:
(9*1)+(8*0)+(7*5)+(6*5)+(5*0)+(4*7)+(3*3)+(2*2)+(1*4)=119
119 % 10 = 9
So 1055073-24-9 is a valid CAS Registry Number.

1055073-24-9Downstream Products

1055073-24-9Relevant academic research and scientific papers

Methods for treatment of renal cell carcinoma

-

, (2008/06/13)

A method of treating renal cell carcinoma in a mammal with that disease comprising administering to the mammal a physiologically effective amount of an inhibitor of PDE10.

Methods for treatment of scleroderma

-

, (2008/06/13)

Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of scleroderma.

Methods for treatment of diseases where GSK 3-beta is desired, and methods to identify compounds usefule for that

-

, (2008/06/13)

A method for selecting compounds for the treatment of diseases where GSK3β is desired includes assessing whether the compounds cause an increase in PKG activity in the tissue of interest.

Methods for treatment of multiple sclerosis

-

, (2008/06/13)

Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of multiple sclerosis.

Methods for treatment of lupus erythematosus

-

, (2008/06/13)

Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of lupus erythematosus.

Method for treating a patient with neoplasia using Iressa

-

Page 19, (2008/06/13)

This invention provides a method for treating a patient with neoplasia by an adjuvant therapy that includes treatment with an inhibitor of human epidermal growth factor receptor tyrosine kinase and a cGMP-specific phosphodiesterase inhibitor.

Methods for treatment of cystic fibrosis

-

, (2008/06/13)

Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of cystic fibrosis.

Methods for treatment of type I diabetes

-

, (2008/06/13)

Substituted condensation products of -benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of type I diabetes.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1055073-24-9